Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
1. 06
-0.02
-1.8519%
$
- Market Cap
- P/E Ratio
- Div Yield
163,800 Volume
-2.14 Eps
$ 1.08
Previous Close
Investors:
Add Transaction
Day Range
1.05 1.09
Year Range
1.05 4.98
Want to track FLNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Filana Therapeutics, Inc. (FLNA) Statistics

Valuation metrics

Market Cap -
Enterprise value -35.37M
Trailing P/E (ttm) -0.66
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) -
Price/Book (mrq) 0.75
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.46

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 162.47K
Average volume (90 days) 369.48K

Price summary

52-Week low 1.05
52-Week high 4.98
Beta -
50-Day moving average 1.28
200-Day moving average 1.64

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 24 Dec 2012
Ex-Dividend Date 13 Dec 2012
Last split factor 1:7
Last split Date 10 May 2017

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -0.72%
Return on equity -1%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.61
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.79
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 2.19%
Book value per share (mrq) 1.41

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -